Navigating the Change: Understanding the 60-Day Dispensing Plan

Introduction: Adapting to Evolving Healthcare Policies

In the realm of healthcare, policy changes often shape patient experiences and healthcare practices. One such change is the upcoming implementation of the 60-day dispensing plan, scheduled to take effect on September 1st. This policy aims to offer extended medication supply on a single prescription. In this blog post, we delve into the details of this new policy, outlining its scope, benefits, and the broader context in which it will operate.

Enhanced Medication Dispensing

Starting from September 2023, individuals managing ongoing health conditions will have the option to receive a two-month supply of medication for the cost of a single prescription. This initiative encompasses more than 300 commonly prescribed medicines listed on the pharmaceutical benefits scheme (PBS). The implementation will occur over three stages within a year, culminating by September 2024. The changes are expected to result in financial savings and convenience for individuals dealing with chronic health issues.


The decision to introduce 60-day prescriptions is based on the recommendations provided by clinical experts associated with the Pharmaceutical Benefits Advisory Committee (PBAC). This approach targets patients with consistent ongoing health conditions who are on stable treatment regimens. A comprehensive list of medicines addressing various health concerns, including asthma, cardiovascular disease, depression, diabetes, and hypertension, is considered suitable for 60-day prescriptions. Doctors retain the discretion to opt for either 30 or 60-day prescriptions based on clinical judgment.  The full list can be viewed here.

Cost-Effective Benefits and Practical Considerations

The adoption of 60-day prescriptions has the potential for economic benefits. Depending on their status, individuals can save up to $180 annually (for general patients) or $43.80 (for concession card holders). Collectively, these savings are projected to exceed $1.6 billion within four years, potentially relieving financial pressures for patients. Furthermore, the new system takes into account the PBS Safety Net, designed to assist patients who exceed specific expenditure thresholds. This initiative aims to enhance the affordability and convenience of obtaining essential medication.


Evaluating the Transition

The implementation of 60-day prescriptions represents a significant shift in medication dispensing practices. While the government asserts potential benefits for patients, it’s important to consider the wider implications of this change, including concerns expressed by the Pharmacy Guild. As the policy takes effect, monitoring its impact on patients, healthcare practitioners, and the healthcare system as a whole will be crucial. The shift to 60-day dispensing reflects an evolving healthcare landscape, influenced by the need for accessibility and affordability, but with various perspectives on its potential outcomes.


  1. Australian Government Department of Health – 60-day Prescriptions for PBS Medicines.
  2. CommBank Pharmacy Insights 2023 Report (May 2023 survey and November 2022 survey).
  3. Professionals Pharmacists Australia Statement on 60-Day Medication Dispensing Concerns.